Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $36.98 Million |
|---|---|
| Enterprise Value | $29.21 Million |
| Earnings per Share | $-0.93 |
| Beta | 0.4 |
| Outstanding Shares | 157,215,046 |
| P/E Ratio | -5.65 |
|---|---|
| PEG | 10.28 |
| Price to Sales | - |
| Price to Book Ratio | 0.24 |
| Enterprise Value to Revenue | 0.27 |
| Enterprise Value to EBIT | -0.31 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.72 |
| Debt to Equity | 0.08 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Senzime AB (publ) is a medical technology firm specializing in the creation and distribution of advanced patient monitoring solutions. These systems are designed to oversee patients undergoing anesthesia across various global markets, in...